Targeting genes in the renin–angiotensin system
TH Le, TM Coffman - Current opinion in nephrology and …, 2008 - journals.lww.com
TH Le, TM Coffman
Current opinion in nephrology and hypertension, 2008•journals.lww.comSince pharmacological antagonists of the renin–angiotensin system are widely used in
clinical medicine, advances in the gene-targeting experiments of the system have helped to
clarify the mechanisms of action of these agents and may provide clues for improved
approaches for the treatment of hypertension and kidney diseases.
clinical medicine, advances in the gene-targeting experiments of the system have helped to
clarify the mechanisms of action of these agents and may provide clues for improved
approaches for the treatment of hypertension and kidney diseases.
Summary
Since pharmacological antagonists of the renin–angiotensin system are widely used in clinical medicine, advances in the gene-targeting experiments of the system have helped to clarify the mechanisms of action of these agents and may provide clues for improved approaches for the treatment of hypertension and kidney diseases.
Lippincott Williams & Wilkins